HAP Trading’s TG Therapeutics TGTX Stock Holding History

HAP Trading’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-70,000	Closed	-$130K	–	1354
2023 Q1	$130K	Sell	70,000 -77,300	-52%	-$1.17M	0.02%	363
2022 Q4	$235K	Buy	147,300 +120,000	+440%	+$871K	0.02%	433
2022 Q3	$13K	Hold	27,300	–	–	﹤0.01%	1267
2022 Q2	$13K	Hold	27,300	–	–	﹤0.01%	1421
2022 Q1	$58K	Buy	27,300 +15,400	+129%	+$178K	﹤0.01%	1214
2021 Q4	$14K	Hold	11,900	–	–	﹤0.01%	1951
2021 Q3	$76K	Sell	11,900 -10,900	-48%	-$337K	﹤0.01%	1369
2021 Q2	$152K	Buy	+22,800	New	+$895K	﹤0.01%	1095
2021 Q1	–	Sell	-28,300	Closed	-$707K	–	2363
2020 Q4	$707K	Buy	+28,300	New	+$956K	0.02%	514
2019 Q4	–	Sell	-14,600	Closed	-$6K	–	1480
2019 Q3	$6K	Sell	14,600 -3,300	-18%	-$23K	﹤0.01%	1112
2019 Q2	$25K	Buy	+17,900	New	+$135K	﹤0.01%	853
2018 Q4	–	Sell	-291,100	Closed	-$11K	–	1288
2018 Q3	$11K	Buy	+291,100	New	+$3.33M	﹤0.01%	838
2015 Q3	–	Sell	-25,400	Closed	-$63K	–	1176
2015 Q2	$63K	Buy	25,400 +400	+2%	+$6.33K	﹤0.01%	626
2015 Q1	$98K	Buy	+25,000	New	+$379K	0.01%	534

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

HAP Trading's TGTX Position: Q1 2022 in Review

HAP Trading sold out of TG Therapeutics (TGTX) in Q1 2022, closing a stake of 24,120 shares — an estimated $279K sold.

HAP Trading first reported a position in TGTX in Q1 2015 and held it in 8 quarters. The position peaked at $1.4M in Q3 2021. 181 funds tracked by Wall St. Rank hold TGTX as of Q1 2022.

HAP Trading reported no remaining TG Therapeutics position as of Q1 2022 after selling out during the quarter.
HAP Trading sold 24,120 TG Therapeutics shares in Q1 2022, an estimated $279K.
HAP Trading first reported a position in TG Therapeutics in Q1 2015 and held it in 8 quarters.
HAP Trading's TG Therapeutics position peaked at $1.4M in Q3 2021.
181 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2022.

Based on HAP Trading's 13F filing for Q1 2022, filed 12 May 2022.